希慎(00014.HK):加路连山道项目 与利园区物业有协同效应
希慎(00014.HK)主席利蕴莲表示,与合作夥伴华懋集团投得加路连山道项目用地,将与利园区的物业组合创造协同效应。
她指,亦希望透过项目持续完善及增补希慎对邻里及社区的愿景,并进一步强化利园区的可持续及循序渐进的增长模式。加路连山道项目内将设有约6万尺绿化空间,而且建议中的全天候有盖行人天桥,将贯通项目所在地、利园区现有物业组合以及铜锣湾港铁站。
她又指,已建立均衡的核心营运业务和稳健的资产负债表,为支持集团持续增长提供强大的後盾,将在未来几年全力以赴,完成加路连山道项目,并将继续推动集团内所有物业组合的持续优化及创新,相信集团未来在香港及其他地方推行发展项目时,将俱备显着优势。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.